Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05452447Not ApplicableCompleted

Spatial Repellents for Aedes-borne Virus Control in Sri Lanka

Role: collaborator

NCT02570152Not ApplicableCompleted

A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia

Role: collaborator

NCT03347136Not ApplicableCompleted

Comparison of Continuous Positive Airway Pressure and Non Invasive Positive Pressure Ventilation

Role: lead

NCT02523456Not ApplicableCompleted

Develop, Implement and Assess Effectiveness of Early Warning Score (EWS) for Moneragala District General Hospital

Role: lead

NCT03111784Not ApplicableCompleted

Effect of Fish Consumption on Cardiovascular Risk Factors

Role: collaborator

NCT02893280Withdrawn

Acute Coronary Syndrome Sri Lanka Audit Project

Role: collaborator

NCT02368392Completed

National Cardiac Arrest Survey

Role: lead

NCT01624064Phase 1Unknown

Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

Role: lead

All 8 trials loaded